Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    HealthTech BioActives, leading globally in Flavonoids and Vitamin B12 Derivatives.

    Virtual Booth

    Contact Supplier

    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Aspen API. More than just an API™

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Menu

    Ketanest

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 314Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Nrx Pharma Resubmits ANDA For Ketafree
    Nrx Pharma Resubmits ANDA For Ketafree

    29 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/29/3157687/0/en/NRx-Pharmaceuticals-Inc-NASDAQ-NRXP-Re-Files-Abbreviated-New-Drug-Application-ANDA-for-KETAFREE-Preservative-Free-IV-Ketamine.html

    GLOBENEWSWIRE
    29 Sep 2025
    Share Share
    Harrow To Acquire Melt Pharmaceuticals
    Harrow To Acquire Melt Pharmaceuticals

    26 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/26/3156941/0/en/Harrow-to-Acquire-Melt-Pharmaceuticals.html

    GLOBENEWSWIRE
    26 Sep 2025
    Share Share
    NRx Pharmaceuticals Implements Expanded Access for NRX-100
    NRx Pharmaceuticals Implements Expanded Access for NRX-100

    27 Aug 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/08/27/3139980/0/en/NRx-Pharmaceuticals-Inc-NASDAQ-NRXP-Announces-Expanded-Access-Policy-for-NRX-100-preservative-free-ketamine.html

    GLOBENEWSWIRE
    27 Aug 2025
    Share Share
    PharmaTher Updates Post FDA Approval for Ketamine (KETARx™)
    PharmaTher Updates Post FDA Approval for Ketamine (KETARx™)

    26 Aug 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/08/26/3139203/0/en/PharmaTher-Provides-Corporate-Update-Following-FDA-Approval-of-Ketamine-KETARx.html

    GLOBENEWSWIRE
    26 Aug 2025
    Share Share
    Silo Pharma's Alzheimer's Candidate SPC-14 Highlighted in Journal
    Silo Pharma's Alzheimer's Candidate SPC-14 Highlighted in Journal

    21 Aug 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/08/21/3137424/0/en/Silo-Pharma-s-Alzheimer-s-Candidate-SPC-14-Featured-in-Leading-Scientific-Peer-reviewed-Journal.html

    GLOBENEWSWIRE
    21 Aug 2025
    Share Share
    PharmaTher Ceo Writes to Shareholders Post Fda Approval
    PharmaTher Ceo Writes to Shareholders Post Fda Approval

    14 Aug 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/08/14/3133406/0/en/PharmaTher-Founder-and-CEO-Issues-Letter-to-Shareholders-following-the-FDA-Approval-of-Ketamine-KETARx.html

    GLOBENEWSWIRE
    14 Aug 2025
    Share Share